Pfm Health Sciences, LP Autolus Therapeutics PLC Transaction History

Pfm Health Sciences, LP

  • $1.71 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$24.21 - $48.01 $5.32 Million - $10.5 Million
-219,628 Closed
0 $0
Q3 2018

Nov 13, 2018
BUY
$20.86 - $33.33 $453,788 - $725,060
21,754 Added 10.99%
219,628 $6.74 Million
Q2 2018

Aug 14, 2018
BUY
$25.0 - $27.75 $4.95 Million - $5.49 Million
197,874 New
197,874 $5.3 Million

Others Institutions Holding AUTL

# of Institutions
104
Shares Held
163M
Call Options Held
2.8K
Put Options Held
13.4K
View Full List

About Autolus Therapeutics plc

AUTL Quotes by TradingView
  • Ticker AUTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 90,909,800
  • Market Cap $272M
  • Description
  • Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...
More about AUTL
Track This Portfolio

Track Pfm Health Sciences, LP Portfolio

Follow Pfm Health Sciences, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pfm Health Sciences, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email